These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15308198)

  • 1. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.
    Liberman SJ; Dagrosa A; Jiménez Rebagliati RA; Bonomi MR; Roth BM; Turjanski L; Castiglia SI; González SJ; Menéndez PR; Cabrini R; Roberti MJ; Batistoni DA
    Appl Radiat Isot; 2004 Nov; 61(5):1095-100. PubMed ID: 15308198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome.
    González SJ; Bonomi MR; Santa Cruz GA; Blaumann HR; Calzetta Larrieu OA; Menéndez P; Jiménez Rebagliati R; Longhino J; Feld DB; Dagrosa MA; Argerich C; Castiglia SG; Batistoni DA; Liberman SJ; Roth BM
    Appl Radiat Isot; 2004 Nov; 61(5):1101-5. PubMed ID: 15308199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
    H-Stenstam B
    Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
    Kiger WS; Lu XQ; Harling OK; Riley KJ; Binns PJ; Kaplan J; Patel H; Zamenhof RG; Shibata Y; Kaplan ID; Busse PM; Palmer MR
    Appl Radiat Isot; 2004 Nov; 61(5):1075-81. PubMed ID: 15308195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT).
    Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B
    Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
    Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
    Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
    Morris GM; Micca PL; Coderre JA
    Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
    Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
    Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.
    Timonen M; Kankaanranta L; Lundbom N; Collan J; Kangasmäki A; Kortesniemi M; Häkkinen AM; Lönngren A; Karjalainen S; Rasilainen M; Leinonen J; Huitti T; Jääskeläinen J; Kouri M; Savolainen S; Heikkinen S
    Eur J Radiol; 2005 Nov; 56(2):154-9. PubMed ID: 16233888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
    Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
    Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
    Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models for estimation of the (10)B concentration after BPA-fructose complex infusion in patients during epithermal neutron irradiation in BNCT.
    Ryynänen PM; Kortesniemi M; Coderre JA; Diaz AZ; Hiismäki P; Savolainen SE
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1145-54. PubMed ID: 11072174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans.
    Kiger WS; Palmer MR; Riley KJ; Zamenhof RG; Busse PM
    Radiat Res; 2001 Apr; 155(4):611-8. PubMed ID: 11260663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boron biodistribution study in colorectal liver metastases patients in Argentina.
    Cardoso J; Nievas S; Pereira M; Schwint A; Trivillin V; Pozzi E; Heber E; Monti Hughes A; Sanchez P; Bumaschny E; Itoiz M; Liberman S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S76-9. PubMed ID: 19375931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron biodistribution in beagles after intravenous infusion of 4-dihydroxyborylphenylalanine-fructose complex.
    Kulvik ME; Vähätalo JK; Benczik J; Snellman M; Laakso J; Hermans R; Järviluoma E; Rasilainen M; Färkkilä M; Kallio ME
    Appl Radiat Isot; 2004 Nov; 61(5):975-9. PubMed ID: 15308178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.